SNPX - Synaptogenix - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

-28.83M

Cash

32.9M

Avg Qtr Burn

-2.034M

Short % of Float

2.93%

Insider Ownership

9.63%

Institutional Own.

3.69%

Qtr Updated

06/30/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Bryostatin-1 Details Alzheimer's disease	Phase 2b Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Bryostatin-1 Details Fragile X syndrome	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.